Temporomandibular disorders (TMD) refer to a group of heterogeneous, pain and dysfunction conditions involving the masticatory system, which influences life quality of the sufferers. Nanofat graft injection in temporomandibular joint (TMJ) is a simple and less invasive surgical procedure for treatment of TMJ problems.
The aim of this study was to evaluate influence and effectiveness of nanofat injection in TMJ for treatment of TMD.
This study was performed in Al-Shaheed Ghazi Al-Hariri Hospital, Department of Oral and Maxillofacial Surgery, Baghdad Medical City from October 2016 and December 2017.
A total of 11 patients (3 males) and (8 females) with range of age 18 to 34 years old.
Every patient was assessed for the following parameters preoperatively: Pain level, maximum mouth opening (MMO), joint clicking, and deviation.
The present study revealed marked female predilection with female ratio about 72.7% (8 patients) and male ratio 27.3% (3 patients), range between 18 and 34 years old. Three patients were presented with single joint (15.8%) and 16 patients were presented with both joints (84.2%).
In general, all patients tolerated treatment procedures without any serious complications during the procedure or after the procedure.
The results of parameters were pain, clicking, and deviation (P < 0.001 HS) and MMO (P < 0.032–0.041 S).
Nanofat injection in TMJ showed therapeutic benefits, simplicity, safety, lack of significant side effects, and complication.
*Ghazi Al-Hariry for Specialized Surgeries Hospital, Medical City Complex
†Ministry of Health
‡Maxillofacial Surgery Unit, Medical City, Baghdad, Iraq.
Address correspondence and reprint requests to Venus H. Mahmmood, FICMS, CABMS, Consultant, Maxillofacial Surgeon, Ghazi Al-Hariry for Specialized Surgeries Hospital, Medical City Complex, Baghdad, Iraq, and Consultant and Supervisor in Council of Arab Board of Oral and Maxillofacial Surgery, Ministry of Health, Baghdad, Iraq; E-mail: email@example.com
Received 15 March, 2018
Accepted 9 July, 2018
The authors report no conflicts of interest.